Risk Of Developing Liver Cancer After HCV Treatment

Wednesday, June 27, 2018

Direct-Acting Antivirals Effective for Hepatitis C in Seniors

MONDAY, June 25, 2018 -- For older patients with hepatitis C virus (HCV), direct-acting antiviral (DAA) therapy is effective, according to a study published online May 25 in the Journal of the American Geriatrics Society.

Chiara Mazzarelli, M.D., from King's College Hospital in London, and colleagues conducted a retrospective review involving individuals aged 65 years and older treated with DAA therapy for HCV. Participants were divided into two cohorts: 88 aged 65 to 74 years and 25 aged 75 years and older.

Abstract
Clinical Investigation Efficacy and Tolerability of Direct‐Acting Antivirals for Hepatitis C in Older Adults 

Articles available on this blog

No comments:

Post a Comment